208 results
8-K
EX-10.1
BBLG
Bone Biologics Corp
6 Mar 24
Bone Biologics Announces Pricing of $2.0 Million Public Offering
4:20pm
of operations and cash flows for the periods then ended, subject, in the case of unaudited statements, to normal, immaterial, year-end audit adjustments.
(i … within a reasonable period of time. In addition, our independent registered public accounting firm, in its audit report to the financial statements
424B4
BBLG
Bone Biologics Corp
4 Mar 24
Prospectus supplement with pricing info
5:21pm
was actively responsible for leading firm audit engagements of publicly held entities in accordance with PCAOB standards and compliance with SEC … registered public accounting firm, in its audit report to the financial statements included in our Annual Report on Form 10-K for the year ended December 31
8-K
cn8vr8w an62
11 Jan 24
Bone Biologics Appoints Healthcare Finance Veteran Robert E. Gagnon to Board of Directors
8:15am
8-K
EX-10.1
kl4cslxu9du alu
20 Nov 23
Bone Biologics Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
7:46am